Both in Pharmaceuticals
Phio Pharmaceuticals vs Aspire-Lakewood Holdings
Over the past year PHIO returned −58.7% and ASBP returned −97.9%; their daily moves had a correlation of -0.03.
PHIO −58.7% ASBP −97.9%Growth of $1, one year, split-adjusted
| Metric | PHIO | ASBP |
|---|---|---|
| Price | $0.8711 | $8.78 |
| Market cap | $10.1M | $12.3M |
| Today | −5.91% | +1.62% |
| 1 month | −14.6% | −3.7% |
| 6 months | −32.5% | +8.5% |
| Year to date | −17.0% | −94.5% |
| 1 year | −61.1% | −97.9% |
| Revenue growth (YoY) | — | — |
| Gross margin | — | 19.5% |
| Net margin | — | −2009.6% |
| P/E (TTM) | — | — |
| Price / sales | — | 126.1× |
| Net cash | $13.0M | $12.2M |
| Dividend yield | — | — |
| Volatility (60d) | 42.8% | 91.8% |
| Short % of float | 0.8% | 1.4% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).